NewAmsterdam Pharma Co N.V. Quarterly Assets in USD from Q4 2022 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary
NewAmsterdam Pharma Co N.V. quarterly Assets history and growth rate from Q4 2022 to Q3 2024.
  • NewAmsterdam Pharma Co N.V. Assets for the quarter ending September 30, 2024 was $439M.
Assets, Quarterly (USD)
Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $439M Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $447M Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $488M Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $347M -$131M -27.5% Dec 31, 2023 10-Q 2024-11-06
Q4 2022 $478M Dec 31, 2022 10-K 2024-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.